Nanobiotix Announces the Appointment of Dr. Gary Phillips as Chairman of the Nanobiotix Supervisory BoardBusiness Wire • 05/25/21
CORRECTING and REPLACING Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical OncologyBusiness Wire • 05/21/21
Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical OncologyBusiness Wire • 05/19/21
NANOBIOTIX to Present Four Posters Including Updates From Priority Head and Neck Cancer and Immunotherapy Development Pathways at the 2021 Annual Meeting of the American Society for Clinical OncologyBusiness Wire • 04/28/21
NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-FBusiness Wire • 04/07/21
NANOBIOTIX Reports Full Year 2020 Financial Results and Highlights Operational ProgressBusiness Wire • 03/17/21
Nanobiotix, PharmaEngine Terminate Development Pact For Radiation Therapy In APAC RegionBenzinga • 03/05/21
NANOBIOTIX: Preclinical Data Presented at First AACR Virtual Special Conference on Radiation Science and Medicine Showed NBTXR3 Combo Overcomes Anti-PD-1 Resistance, Promotes Strong Abscopal Effect and Long-Term Anti-Cancer MemoryBusiness Wire • 03/02/21
Nanobiotix Announces Positive First Results for Novel NBTXR3 in Rectal Cancer Study at ASCO-GI 2021Business Wire • 01/15/21
Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public OfferingBusiness Wire • 01/08/21
Nanobiotix Announces Closing of Underwriters' Option to Purchase Additional ADSsBusiness Wire • 12/18/20
NANOBIOTIX Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $113.3 MillionBusiness Wire • 12/15/20
NANOBIOTIX Announces Pricing of Global Offering and Approval to List on NASDAQ Global Select MarketBusiness Wire • 12/11/20
NANOBIOTIX Announces the Filing of an Amended Registration Statement, Including an Estimated Initial Public Offering RangeBusiness Wire • 12/10/20